Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study

Published on Nov 1, 2019in Lancet Oncology33.752
· DOI :10.1016/S1470-2045(19)30456-5
Melina Arnold24
Estimated H-index: 24
(IARC: International Agency for Research on Cancer),
Mark J. Rutherford17
Estimated H-index: 17
(IARC: International Agency for Research on Cancer)
+ 35 AuthorsFreddie Bray119
Estimated H-index: 119
(IARC: International Agency for Research on Cancer)
Summary Background Population-based cancer survival estimates provide valuable insights into the effectiveness of cancer services and can reflect the prospects of cure. As part of the second phase of the International Cancer Benchmarking Partnership (ICBP), the Cancer Survival in High-Income Countries (SURVMARK-2) project aims to provide a comprehensive overview of cancer survival across seven high-income countries and a comparative assessment of corresponding incidence and mortality trends. Methods In this longitudinal, population-based study, we collected patient-level data on 3·9 million patients with cancer from population-based cancer registries in 21 jurisdictions in seven countries (Australia, Canada, Denmark, Ireland, New Zealand, Norway, and the UK) for seven sites of cancer (oesophagus, stomach, colon, rectum, pancreas, lung, and ovary) diagnosed between 1995 and 2014, and followed up until Dec 31, 2015. We calculated age-standardised net survival at 1 year and 5 years after diagnosis by site, age group, and period of diagnosis. We mapped changes in incidence and mortality to changes in survival to assess progress in cancer control. Findings In 19 eligible jurisdictions, 3 764 543 cases of cancer were eligible for inclusion in the study. In the 19 included jurisdictions, over 1995–2014, 1-year and 5-year net survival increased in each country across almost all cancer types, with, for example, 5-year rectal cancer survival increasing more than 13 percentage points in Denmark, Ireland, and the UK. For 2010–14, survival was generally higher in Australia, Canada, and Norway than in New Zealand, Denmark, Ireland, and the UK. Over the study period, larger survival improvements were observed for patients younger than 75 years at diagnosis than those aged 75 years and older, and notably for cancers with a poor prognosis (ie, oesophagus, stomach, pancreas, and lung). Progress in cancer control (ie, increased survival, decreased mortality and incidence) over the study period was evident for stomach, colon, lung (in males), and ovarian cancer. Interpretation The joint evaluation of trends in incidence, mortality, and survival indicated progress in four of the seven studied cancers. Cancer survival continues to increase across high-income countries; however, international disparities persist. While truly valid comparisons require differences in registration practice, classification, and coding to be minimal, stage of disease at diagnosis, timely access to effective treatment, and the extent of comorbidity are likely the main determinants of patient outcomes. Future studies are needed to assess the impact of these factors to further our understanding of international disparities in cancer survival. Funding Canadian Partnership Against Cancer; Cancer Council Victoria; Cancer Institute New South Wales; Cancer Research UK; Danish Cancer Society; National Cancer Registry Ireland; The Cancer Society of New Zealand; National Health Service England; Norwegian Cancer Society; Public Health Agency Northern Ireland, on behalf of the Northern Ireland Cancer Registry; The Scottish Government; Western Australia Department of Health; and Wales Cancer Network.
📖 Papers frequently viewed together
34.6k Citations
201860.39The Lancet
1,370 Citations
1 Author (Jacqui Wise)
#1Michael EdenH-Index: 3
#2Samantha HarrisonH-Index: 5
Last. Jem Rashbass (PHE: Public Health England)H-Index: 17
view all 19 authors...
Abstract Background International cancer survival comparisons use cancer registration data to report cancer survival, which informs the development of cancer policy and practice. Studies like the International Cancer Benchmarking Partnership (ICBP) have a duty to understand how registration differences impact on survival prior to drawing conclusions. Methods Key informants reported differences in registration practice for capturing incidence date, death certificate case handling and registration...
11 CitationsSource
Summary Background In 2015, the second cycle of the CONCORD programme established global surveillance of cancer survival as a metric of the effectiveness of health systems and to inform global policy on cancer control. CONCORD-3 updates the worldwide surveillance of cancer survival to 2014. Methods CONCORD-3 includes individual records for 37·5 million patients diagnosed with cancer during the 15-year period 2000–14. Data were provided by 322 population-based cancer registries in 71 countries an...
1,370 CitationsSource
Abstract Background A new cancer patient pathway for patients presenting with non-specific signs and symptoms (NSSC-CPP) was implemented nationally in Denmark in 2012. This study aims to describe, on a national level, the characteristics of patients referred to the Danish NSSC-CPP, and to estimate the prevalence and distribution of cancers and other diagnosis in this population. Methods A population-based cohort study using the Danish national registries, including all patients who completed a d...
15 CitationsSource
#1Enzo CovielloH-Index: 4
#2Karri SeppäH-Index: 1
Last. Arun Pokhrel (U of A: University of Alberta)H-Index: 10
view all 4 authors...
Cancer registries are often interested in estimating net survival (NS), the probability of survival if the cancer under study is the only possible cause of death. Pohar Perme, Stare, and Esteve (2012, Biometrics 68: 113–120) proposed a new estimator of NS based on inverse probability weighting. They demonstrated that existing estimators of NS based on relative survival were biased, whereas the new estimator was unbiased. The new estimator was developed for continuous survival times, yet cancer r...
13 CitationsSource
#1Claus Anders Bertelsen (UCPH: University of Copenhagen)H-Index: 14
#2Anders U Neuenschwander (UCPH: University of Copenhagen)H-Index: 6
Last. Ismail Gögenur (UCPH: University of Copenhagen)H-Index: 37
view all 13 authors...
Summary Background Application of the principles of total mesorectal excision to colon cancer by undertaking complete mesocolic excision (CME) has been proposed to improve oncological outcomes. We aimed to investigate whether implementation of CME improved disease-free survival compared with conventional colon resection. Methods Data for all patients who underwent elective resection for Union for International Cancer Control (UICC) stage I–III colon adenocarcinomas in the Capital Region of Denma...
285 CitationsSource
#1Roberta De Angelis (ISS: Istituto Superiore di Sanità)H-Index: 28
#2Milena SantH-Index: 59
Last. Riccardo Capocaccia (ISS: Istituto Superiore di Sanità)H-Index: 62
view all 16 authors...
Summary Background Cancer survival is a key measure of the effectiveness of health-care systems. EUROCARE—the largest cooperative study of population-based cancer survival in Europe—has shown persistent differences between countries for cancer survival, although in general, cancer survival is improving. Major changes in cancer diagnosis, treatment, and rehabilitation occurred in the early 2000s. EUROCARE-5 assesses their effect on cancer survival in 29 European countries. Methods In this retrosp...
1,221 CitationsSource
#1John Butler (The Royal Marsden NHS Foundation Trust)H-Index: 14
#2Catherine Foot (King's Fund)H-Index: 4
Last. Michael RichardsH-Index: 58
view all 9 authors...
The International Cancer Benchmarking Partnership (ICBP) was initiated by the Department of Health in England to study international variation in cancer survival, and to inform policy to improve cancer survival. It is a research collaboration between twelve jurisdictions in six countries: Australia (New South Wales, Victoria), Canada (Alberta, British Columbia, Manitoba, Ontario), Denmark, Norway, Sweden, and the United Kingdom (England, Northern Ireland, Wales). Leadership is provided by policy...
72 CitationsSource
#1Sarah Walters (Lond: University of London)H-Index: 11
#2Camille Maringe (Lond: University of London)H-Index: 18
Last. Bernard Rachet (Lond: University of London)H-Index: 51
view all 23 authors...
Background The authors consider whether differences in stage at diagnosis could explain the variation in lung cancer survival between six developed countries in 2004–2007. Methods Routinely collected population-based data were obtained on all adults (15–99 years) diagnosed with lung cancer in 2004–2007 and registered in regional and national cancer registries in Australia, Canada, Denmark, Norway, Sweden and the UK. Stage data for 57 352 patients were consolidated from various classification sys...
297 CitationsSource
#1Camille Maringe (Lond: University of London)H-Index: 18
#2Sarah Walters (Lond: University of London)H-Index: 11
Last. Michel P Coleman (Lond: University of London)H-Index: 81
view all 22 authors...
Background. Large international differences in colorectal cancer survival exist, even between countries with similar healthcare. We investigate the extent to which stage at diagnosis explains these differences. Methods. Data from population-based cancer registries in Australia, Canada, Denmark, Norway, Sweden and the UK were analysed for 313 852 patients diagnosed with colon or rectal cancer during 2000-2007. We compared the distributions of stage at diagnosis. We estimated both stage-specific n...
150 CitationsSource
#1Sarah Walters (Lond: University of London)H-Index: 11
#2Camille Maringe (Lond: University of London)H-Index: 18
Last. Michel P Coleman (Lond: University of London)H-Index: 81
view all 23 authors...
Background: We investigate whether differences in breast cancer survival in six high-income countries can be explained by differences in stage at diagnosis using routine data from population-based cancer registries. Methods: We analysed the data on 257 362 women diagnosed with breast cancer during 2000-7 and registered in 13 population-based cancer registries in Australia, Canada, Denmark, Norway, Sweden and the UK. Flexible parametric hazard models were used to estimate net survival and the exc...
141 CitationsSource
Cited By200
#1Joseph Akanuwe (University of Lincoln)H-Index: 1
#2Sharon Black (University of Lincoln)H-Index: 4
Last. Aloysius Niroshan Siriwardena (University of Lincoln)H-Index: 14
view all 4 authors...
Aim We aimed to explore service users’ and primary care practitioners’ perspectives on the barriers and facilitators to implementing a cancer risk assessment tool, QCancer, in general practice consultations. Background Cancer risk assessment tools, including QCancer, are designed to estimate the chances of previously undiagnosed cancer in symptomatic individuals. Little is known about the barriers and facilitators to implementing cancer risk assessment tools in primary care consultations. Method...
#1Eun Young Kang (U of C: University of Calgary)H-Index: 2
#2Nicholas Wiebe (U of C: University of Calgary)H-Index: 2
Last. Martin Köbel (U of C: University of Calgary)H-Index: 61
view all 10 authors...
The World Health Organization endorses molecular subclassification of endometrial endometrioid carcinomas (EECs). Our objectives were to test the sensitivity of tumor morphology in capturing p53 abnormal (p53abn) cases and to model the impact of p53abn on changes to ESGO/ESTRO/ESP (European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology) risk stratification. A total of 292 consecutive endometrial carcinoma resections received at Fo...
#1Johnathan R. Lex (Royal Orthopaedic Hospital)H-Index: 5
#2Scott Evans (Royal Orthopaedic Hospital)H-Index: 10
Last. Jonathan D Stevenson (Royal Orthopaedic Hospital)H-Index: 13
view all 5 authors...
Aims null Proximal femoral endoprosthetic replacements (PFEPRs) are the most common reconstruction option for osseous defects following primary and metastatic tumour resection. This study aimed to compare the rate of implant failure between PFEPRs with monopolar and bipolar hemiarthroplasties and acetabular arthroplasties, and determine the optimum articulation for revision PFEPRs. null Methods null This is a retrospective review of 233 patients who underwent PFEPR. The mean age was 54.7 years (...
1 CitationsSource
#1Feng Peng (HUST: Huazhong University of Science and Technology)H-Index: 12
#2Tingting Qin (HUST: Huazhong University of Science and Technology)H-Index: 1
Last. Renyi Qin (HUST: Huazhong University of Science and Technology)H-Index: 17
view all 8 authors...
Background: Pancreatic head ductal adenocarcinoma (PHDAC) patients with the same Tumour-Node-Metastasis (TNM) stage may share different outcomes after pancreaticoduodenectomy (PD). Therefore, a novel method to identify patients with poor prognosis after PD is urgently needed. We aimed to develop a nomogram to estimate survival in PHDAC after PD. Methods: To estimate survival after PD, a nomogram was developed using the Tongji Pancreatic cancer cohort comprising 355 PHDAC patients who underwent P...
#1Patricia Piña-Sánchez (Mexican Social Security Institute)H-Index: 14
#2Antonieta Chávez-González (Mexican Social Security Institute)H-Index: 9
Last. Hector Mayani (Mexican Social Security Institute)H-Index: 24
view all 9 authors...
Since the second half of the 20th century, our knowledge about the biology of cancer has made extraordinary progress. Today, we understand cancer at the genomic and epigenomic levels, and we have i...
#1Reino Heikkilä (Oslo University Hospital)H-Index: 15
#2Tor Åge MyklebustH-Index: 15
Last. Bjørn MøllerH-Index: 12
view all 3 authors...
Background null Cancer services in Norway are intended to provide high quality services and equal access for all citizens. Still, regional variation in cancer survival has been reported. Currently, the public hospitals are organized in Health Trusts (HTs), respectively within one of four regional trusts (RHTs). We aimed to evaluate the extent and rank pattern of regional and intraregional variation in cancer survival systematically over the last three decades. We postulated that organizational r...
#1Bjørn MøllerH-Index: 12
Last. Tor Åge MyklebustH-Index: 15
view all 7 authors...
BACKGROUND Death certificates are an important source of information for cancer registries. The aim of this study was to validate the cancer information on death certificates, and to investigate the effect of including death certificate initiated (DCI) cases in the Cancer Registry of Norway when estimating cancer incidence and survival. METHODS All deaths in Norway in the period 2011-2015 with cancer mentioned on the death certificates were linked to the cancer registry. Notifications not regist...
#1John C. Taylor (University of Leeds)H-Index: 21
#2Lene Hjerrild Iversen (Aarhus University Hospital)H-Index: 28
Last. Philip Quirke (University of Leeds)H-Index: 101
view all 9 authors...
Aim null Denmark and Yorkshire are demographically similar and both have undergone changes in their management of colorectal cancer to improve outcomes. The differential provision of surgical treatment, especially in the older age groups, may contribute to the magnitude of improved survival rates. This study aimed to identify differences in the management of colorectal cancer surgery and postoperative outcomes according to patient age between Denmark and Yorkshire. null Method null This was a re...
#1Raymond Javan Chan (Flinders University)H-Index: 21
#2Megan Crichton (Flinders University)H-Index: 5
Last. Margaret I. Fitch (U of T: University of Toronto)H-Index: 45
view all 20 authors...
Background null Telemedicine services have been increasingly used to facilitate post-treatment cancer survivorship care, including improving access; monitoring health status, health behaviors, and symptom management; enhancing information exchange; and mitigating the costs of care delivery, especially since the COVID-19 pandemic. To inform guidance for the use of telemedicine in the post-COVID era, the aim of this overview of systematic reviews (SRs) was to evaluate the efficacy of, and survivor...
1 CitationsSource
#1Freddie Bray (IARC: International Agency for Research on Cancer)H-Index: 119
#2Mathieu Laversanne (IARC: International Agency for Research on Cancer)H-Index: 19
Last. Isabelle Soerjomataram (IARC: International Agency for Research on Cancer)H-Index: 50
view all 7 authors...
With the 2030 Sustainable Development Goals (SDG) target of a one-third reduction in noncommunicable diseases (NCDs) less than a decade away, it is timely to assess national progress in reducing premature deaths from the two leading causes of mortality worldwide. We examine trends in the probability of dying ages 30-70 from cardiovascular disease (CVD) and cancer 2000-19 in 10 middle-income (MICs) and 10 high-income (HICs) countries with high quality data. We then predict whether the SDG target ...